MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.

Source:http://linkedlifedata.com/resource/pubmed/id/21336260

Download in:

View as

General Info

PMID
21336260